People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...